With the completion of a Phase I/II clinical  trial for its skin graph substitute, StrataGraph, Madison company, Stratatech is charging forward to bring its product to market.

Click here to read more from the Milwaukee Journal Sentinel.

Lynn Allen-Hoffman, president and CEO of Stratatech Corp.

Photo by Joe Koshollek, Milwauke Journal Sentinel